ADAR1 Capital Management reports acquisition of $62,897.0667 in NextCure common shares
NXTC•ADAR1 Capital Management reported purchasing 12,333 NextCure common shares at $5.0999 per share, bringing its reported indirect beneficial ownership to 750,289 shares.
1. Share purchase
ADAR1 Capital Management reported buying 12,333 NextCure common shares at $5.0999 per share. The transaction brought reported indirect beneficial ownership to 750,289 shares; ADAR1 Capital Management and its manager, Daniel Schneeberger, are listed as 10% owners.
